First cancer gene therapy to pass phase III

A gene therapy developed at M. D. Anderson Cancer Center for head and neck cancer is the first such treatment to succeed in a phase III trial. See the press release for more details.

(Phase III studies are large, multi-institutional studies required for regulatory approval of new drugs.)

Leave a Reply

Your email address will not be published.